- Filed
- Feb 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 3, 2025 | 154.97M sh |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $3.83B |
| Long Term Debt | Q2 2025 · Jun 30, 2024 | $4.03B |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $27.21M |
| Short Term Debt | Q2 2025 · Jun 30, 2024 | $73.77M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $5.17B |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $5.21B |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $1.31B |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $1.34B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $6.23B |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $6.54B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $3.5B |
| Current Assets | Q2 2025 · Jun 30, 2024 | $3.66B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $14.2B |
| Total Assets | Q2 2025 · Jun 30, 2024 | $14.49B |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $926.03M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $856.26M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 151.56M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 150.95M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $153.67M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $265.97M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.38 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$1.03 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.38 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$1.03 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $209.16M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $420.86M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $111.16M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $224.65M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$26.99M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$94.53M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $780.79M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $1.53B |
| Revenue | Q2 2025 · Dec 31, 2023 | $1.13B |
| Revenue | Q2 2025 · Dec 31, 2023 | $2.18B |